Showing results (341-350 of 710) with videos related to

Sort By:
Pageof 71
Immunobiology|July 26, 2011
Mice expressing human CR1/CD35 have an enhanced humoral immune response to T-dependent antigens but fail to correct the effect of premature human CR2 expressionIsabel Y Pappworth, Christine Hayes, Jason Dimmick, et al.
Diagnostic and Interventional Imaging|July 15, 2019
Acetic acid versus radiofrequency ablation for the treatment of hepatocellular carcinoma: A randomized controlled trialS B Paul, S K Acharya, S R Gamanagatti, et al.
The Journal of Biological Chemistry|November 13, 2004
Molecular dissection of interactions between components of the alternative pathway of complement and decay accelerating factor (CD55)Claire L Harris, Rachel J M Abbott, Richard A Smith, et al.
The American Journal of Pathology|October 19, 2010
The alternative and terminal pathways of complement mediate post-traumatic spinal cord inflammation and injuryFei Qiao, Carl Atkinson, Mark S Kindy, et al.
Blood|March 24, 2012
A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancerMichelle Elvington, Yuxiang Huang, B Paul Morgan, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|August 1, 2013
Evidence for triclosan-induced activation of human and rodent xenobiotic nuclear receptorsKatie B Paul, Jerry T Thompson, Steven O Simmons, et al.
Gene Therapy|June 29, 2000
B7.1 expression by the weakly immunogenic F98 rat glioma does not enhance immunogenicityD B Paul, R F Barth, W Yang, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|December 26, 2001
Experimental prostate epithelial morphogenesis in response to stroma and three-dimensional matrigel cultureS H Lang, M Stark, A Collins, et al.
Molecular Immunology|July 27, 2007
Prevention of experimental autoimmune myasthenia gravis by rat Crry-Ig: A model agent for long-term complement inhibition in vivoNatalie J Hepburn, Jayne L Chamberlain-Banoub, Anwen S Williams, et al.
Journal of Neuroinflammation|August 15, 2015
Adjuvant treatment with dexamethasone plus anti-C5 antibodies improves outcome of experimental pneumococcal meningitis: a randomized controlled trialE Soemirien Kasanmoentalib, Mercedes Valls Seron, B Paul Morgan, et al.
Pageof 71